GUTS CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Fractyl (NASDAQ: GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

NEW YORK--(BUSINESS WIRE)--Oct 20, 2026--

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fractyl Health, Inc. ("“Fractyl” or the “Company”) (NASDAQ: GUTS) and reminds investors of the October 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020695255/en/

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Revita was less effective than Defendants had led investors to believe, and/or operational issues at one or more of the REMAIN-1 Midpoint Cohort's clinical sites compromised the integrity of its efficacy results; (ii) accordingly, Revita's clinical, regulatory, and commercial prospects were overstated, as was the REMAIN-1 Midpoint Cohort's ability to assess Revita's efficacy; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.

On January 29, 2026, Fractyl issued a press release announcing six-month data from the REMAIN-1 Midpoint Cohort, disclosing that "Revita-treated patients experienced a 4.5% weight regain vs 7.5% in the sham arm at 6 months" and that "[t]he Midpoint Cohort was not designed to be sufficiently powered for efficacy analysis," and hosted a conference call during which CEO Rajagopalan indicated that issues at one of the study sites "had higher-than-expected regain across both arms." On this news, Fractyl's stock price fell $1.245, or 68.03%, to close at $0.585 per share on January 29, 2026.

On January 30, 2026, following the release of post-market Canaccord Genuity and Morgan Stanley reports, with Morgan Stanley downgrading the Company to "Equal-weight" from "Overweight" and cutting its price target to $2.00 from $8.00, characterizing the results as "[d]isappoint[ing]." On this news, Fractyl's stock price fell $0.125, or 21.37%, to close at $0.46 per share on January 30, 2026.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Fractyl’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Fractyl class action, go to www.faruqilaw.com/GUTS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Fractyl Securities Class Action Lawsuit:

What is the Fractyl securities fraud lawsuit about?

Faruqi & Faruqi, LLP has filed a securities class action lawsuit against Fractyl Health, Inc. (NASDAQ: GUTS) and certain of its officers and directors on behalf of investors who purchased Fractyl securities during the Class Period. The complaint alleges that Defendants made materially false and misleading public statements regarding Revita, the Company's investigational treatment, by allegedly overstating its clinical effectiveness and the ability of the REMAIN-1 Midpoint Cohort to assess its efficacy. The lawsuit further alleges that operational issues at one or more clinical study sites may have compromised the integrity of the Midpoint Cohort's efficacy results, and that Revita's clinical, regulatory, and commercial prospects were accordingly overstated. On January 29, 2026, Fractyl allegedly disclosed that the Midpoint Cohort "was not designed to be sufficiently powered for efficacy analysis" and that site-level issues had affected results across study arms, causing the Company's stock price to fall approximately 68% in a single trading session.

Who may be eligible to participate in the lawsuit?

Investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities on the NASDAQ exchange between January 13, 2025 and January 29, 2026, inclusive, may be eligible to participate in this lawsuit as class members. Eligibility is not limited to those who seek appointment as lead plaintiff; any investor who purchased Fractyl securities during the Class Period and suffered losses may potentially share in any recovery obtained on behalf of the class. Investors are encouraged to review their trading records to determine whether their purchases fall within the applicable Class Period. Participation in a class action does not require that an investor take any active role in the litigation beyond potentially providing information if contacted.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff is a court-appointed representative who acts on behalf of all class members in directing the litigation, including selecting and working with class counsel to advance the interests of the investor class. Any class member who suffered losses during the Class Period may move the court for appointment as lead plaintiff, but investors are not required to serve in this role in order to be eligible to share in any recovery the litigation may produce. Under the Private Securities Litigation Reform Act, a motion for appointment as lead plaintiff must be filed no later than October 20, 2026. Investors who wish to be considered for the lead plaintiff role should consult with qualified securities counsel promptly, as this deadline is fixed by statute and is not typically subject to extension.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Fractyl securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

GUTS CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Fractyl (NASDAQ: GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

JUBA, South Sudan (AP) — A drone strike on a market in Abyei, a border region disputed by Sudan and South Sudan, hit a nearby fuel depot, killing at least 153 people and igniting a fire that was still burning Tuesday, a local official said.

Yohanna Akol Ngor, the Abyei administration’s caretaker information minister, blamed Sudan ’s military for Monday’s attack on Amiet Market, north of Abyei town.

“We have recorded 153 deaths,” Ngor told The Associated Press by phone Tuesday. He said the death toll continued to rise as the fire burned.

A senior Sudanese military officer said the army carried out a drone strike Monday targeting fuel tankers arriving from South Sudan that he said were bound for the paramilitary Rapid Support Forces. He spoke on condition of anonymity because he was not authorized to speak to the press.

The officer said those killed were RSF members and people involved in fuel smuggling. “We do not target civilians,” he said. The AP could not independently verify his account of the targets or the identities of those killed.

The officer said the strike took place outside the demilitarized zone along the border with South Sudan.

Doctors Without Borders, known by its French acronym MSF, said more than 20 wounded people were brought to Ameth Bek Hospital, where MSF teams were working alongside staff from South Sudan’s Health Ministry.

“So far we received over 20 patients, including several critical cases. Patients with burns were also admitted,” said Dr. Christian Lindauer, MSF’s medical activities manager at the hospital.

South Sudan’s Foreign Ministry also blamed Sudan’s military, saying the attack hit multiple locations within the market, causing civilian casualties and extensive property damage.

The ministry said it had summoned Sudan’s ambassador to protest and urged Sudan to “refrain from any actions that endanger civilian lives and property.” It called for issues concerning Abyei to be addressed through diplomatic channels.

Sudan’s military and the paramilitary Rapid Support Forces have been fighting since April 2023, devastating large parts of the country and threatening stability along its borders.

Ngor said the strike hit around 11 a.m. Monday. He said the fuel depot supplied local businesses.

“It is a horrible and shocking situation,” he said.

MSF called on all parties to stop attacks on civilians and civilian infrastructure, expressing concern about people’s ability to safely reach healthcare and other essential services.

Amiet Market is a trading hub serving the Ngok Dinka and Misseriya communities.

The oil-rich Abyei region’s status was left unresolved by a 2005 peace agreement that ended decades of civil war and remained unsettled when South Sudan became independent in 2011. A proposed referendum stalled over disagreements about who could vote.

The region’s majority Ngok Dinka population favors joining South Sudan, while Misseriya nomads who use its pastures favor Sudan. Abyei has also experienced deadly communal violence, including fighting over land between Ngok Dinka and neighboring Twic Dinka communities.

Yassir Abdalla contributed from Shendi, Sudan.

FILE - The silhouettes of South Sudanese people are seen through a South Sudanese flag as they line up to cast their votes in Juba, South Sudan, Jan. 9, 2011. (AP Photo/Jerome Delay, File)